 WALTHAM, Mass., April 04, 2022 GLOBE NEWSWIRE -- Checkpoint Therapeutics, Inc. Checkpoint NASDAQ: CKPT, a clinical-stage immunotherapy and targeted oncology company, today announced that members of Checkpoints management team will participate in the two-day Fortress Biotech Fortress Virtual RD Summit taking place on Tuesday, April 5, 2022 and Wednesday, April 6, 2022. The Summit will be hosted by the B. Riley Securities Healthcare Equity Research team and will feature multiple programs from Fortress diversified pipeline. 